It should not replace personalized advice from qualified healthcare providers
Metabolic Health Improvements Beyond weight loss, participants on semaglutide 7.2 mg experienced comprehensive metabolic improvements including significant reductions in waist circumference, improvements in blood pressure control, enhanced glycemic parameters, and favorable cholesterol profile changes
Additional Cost Management Strategies Organizations exploring GLP-1 coverage are also considering targeted cost-control measures, including: Setting clinical qualification standards based on BMI and related conditions Establishing duration or lifetime coverage limits where allowed Adjusting copays or deductibles for obesity-related medications Favoring lower-utilization or lower-cost therapeutic alternatives within the formulary Evaluating alternative treatments such as bariatric surgery, which may produce durable outcomes at comparable costs to a year of medication therapy These strategies allow employers to maintain access while aligning coverage with financial objectives
An effective physician-supervised medical weight management program can help alleviate many of the other conditions that result from obesity, including diabetes, arthritis, diabetes, sleep apnea, high cholesterol and others
GLP-1 medications can cause digestive side effects